| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.5× | −1.7× | |
| Price / Book | 0.4× | 2.0× | |
| Price / Sales | 0.6× | 4.0× | |
| Price / Free cash flow | −10.1× | −1.5× | |
| EV / EBITDA | −1.3× | −1.2× | |
| Earnings yield | −195.5% | −14.3% | |
| Free cash flow yield | −9.9% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,301.72 | +4.95% | $1.23T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.49 | +2.25% | $625.34B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.20 | +1.95% | $509.28B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $416.73 | +2.42% | $374.05B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.25 | +3.22% | $365.76B | 19.4× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.69 | +1.66% | $281.48B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $167.91 | +2.42% | $260.41B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $685.14 | +0.85% | $253.33B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.43 | +2.47% | $235.41B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.34 | +1.48% | $192.61B | 22.3× | 37.5% | +29.9% |
